SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Braintech
Braintech Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Braintech Spółka z Ograniczoną Odpowiedzialnością
Braintech Spółka z Ograniczoną Odpowiedzialnością (KRS 0000422201, NIP 5213631431) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. BRAINTECH operates in: Other research and experimental development on natural sciences and engineering (PKD 72.19.Z). Industry: Research and development. The company has been listed in the National Court Register since May 28, 2012. BRAINTECH's most recently reported net revenue was 74.7 K PLN for 2024.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
72.19.ZOther research and experimental development on natural sciences and engineering
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
HTTP://BRAINTECH.PLCredibility rating
42.9 / 100
Average credibility
Insolvency risk
Very low
Elevated threat
Closure risk
18
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
5
5/14 yrs
Board changes
3
3/14 yrs
PKD changes
1
1/14 yrs
Name changes
0
0/14 yrs
Data from 14 years of registry activity.
Payment reliability score from 2018–2024
Current: D (43/100)
Trend: improving (+4.4 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Standard limit from 2018–2024
Current: 2.1 K PLN
Safe: 632.17 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
May 28, 2012
14 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
72.19.Z
Other research and experimental development on natural sciences and…
Share capital
595.0 K PLN
1,190 shares total
Shareholders
3
shareholders
Board
2 people
Filed years
7 years
2018–2024 · profitable: 3/7
Registry entries
31
latest: July 16, 2025
Risk signals
Revenue
74.7 K PLN
2024
Net profit
-30.7 K PLN
2024
Assets
143.1 K PLN
2024
Equity
102.4 K PLN
2024
Valuation
66.3 K PLN
Low confidence
Low confidence
Projects co-financed by the European Union for Braintech - total value, EU contribution and the company's largest awards.
Projects
1
EU co-financing
476.2 K PLN
Total project value
830.3 K PLN
Eligible spending
672.0 K PLN
Funds
Operational programmes
Top 1 by EU co-financing
| Project | Fund | EU co-financing | Value | Rate | Period |
|---|---|---|---|---|---|
Rozwój przedsiębiorstwa BrainTech Sp. z o.o. poprzez opracowanie nowego projektu wzorniczego bezprzewodowego headsetu EEG. |
Rate business credibility - Braintech.
No ratings
News
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase regarding BCX-CM-J - Europe's first veterinary cell-therapy drug from mesenchymal stem cells for dogs with osteoarthritis. Responses to the final EMA questions are due in May 2026; the CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. Pre-commercial biotech: 2024 closed with a PLN 14.9 m loss on zero revenue; cash of PLN 33.6 m at year-end. Trigon DM maintained a buy rating with a price target of PLN 127.2.
News
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) - a pre-commercial biotech specialising in TPD (Targeted Protein Degradation) - closed Q3 2025 with PLN 36 m of cash and grants securing financing to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I - the first patient dosed at Barcelona Clinic Liver Cancer. CT-03 (MCL-1 degrader) nearing clinical entry. Without a new R&D partnership or equity issuance in 2026, the company will need additional financing.
| EFRR |
| 476.2 K PLN |
| 830.3 K PLN |
| 71% |
| 2019–2021 |
Latest reporting year
2024
Available years
13
Filing entries
0
20 historical registry entries for Braintech
Board change
WA.XIII NS-REJ.KRS/516/22/240
Filing documents submitted (2 documents)
Filing documents submitted (2 documents)
Filing documents submitted (2 documents)
Filing documents submitted (2 documents)
Public-procurement proceedings in which Braintech appears as contractor or contracting authority - total contract value, signing dates, procedures and links to the official notices.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
BRAINTECH's board has 2 members.
Competing companies or those operating in the same market segment as Braintech (in Warszawa, industry: Research and development).
WARSZAWA· Research and development
Revenue 2024: 2.9 B PLN
WARSZAWA· Research and development
Revenue 2024: 796.1 M PLN
WARSZAWA· Research and development
Revenue 2023: 609.6 M PLN
WARSZAWA· Research and development
Revenue 2024: 579.9 M PLN
WARSZAWA· Research and development
Revenue 2024: 499.5 M PLN
OTWOCK· Research and development
Revenue 2025: 403.1 M PLN
Company Braintech has only one trademark, which is a trademark "BCI APPLIANCE".
3 most recent trademarks
BCI APPLIANCE
Filing date: 2018-04-12
expired
